We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
If a product is manufactured using a human embryo or a human embryonic stem cell, or any material sourced from a human embryo or human embryonic stem cell, a statement to this effect must be included in the product’s Product Information (PI) and Consumer Medicine Information (CMI) documents.
It is no longer a requirement that a separate declaration concerning the use of such material be completed and included in Module 1 of a submission. The Declaration: Therapeutic goods and use of human embryos or human embryonic stem cells or material derived therefrom form is no longer in use.
Instead, a declaration must now be made in Part B of Module 1.2.1: Application form to register or vary the registration of prescription medicines. Go to the form: